Joel M Gelfand MD MSCE FAAD Profile picture
Leyden Professor of #Dermatology & #Epidemiology @PENN. Tweets my own/not advice. #psoriasis #trials #COVID19 #FAAD BS @TuftsUniversity MD @HarvardMed
Jul 31, 2022 5 tweets 2 min read
@AADmember here's what I'll tell my patients about #ZORYVE (#roflumilast) cream: It's used once a day for the treatment of #psoriasis in people 12 years or older. About 39% of patients achieve clear or almost clear skin with ZORYVE (roflumilast) cream after 8 weeks of use. https://www.arcutis.com/wp-...Image The most common side effects (occurring in 1-3% of people) are diarrhea, headache, difficulty sleeping, nausea, pain at site of application, and infection. Only apply ZORYVE (roflumilast) cream to your psoriasis, and wash your hands after application.